Carillon Tower Advisers’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$23.5M Sell
230,821
-28,638
-11% -$2.69M 0.14% 212
2020
Q3
$21.8M Sell
259,459
-1,620
-0.6% -$126K 0.29% 120
2020
Q2
$17M Sell
261,079
-11,875
-4% -$784K 0.13% 220
2020
Q1
$17.8M Sell
272,954
-22,925
-8% -$1.81M 0.17% 189
2019
Q4
$23.3M Sell
295,879
-25,600
-8% -$1.99M 0.16% 226
2019
Q3
$25.6M Sell
321,479
-5,675
-2% -$446K 0.18% 206
2019
Q2
$27.4M Sell
327,154
-75,496
-19% -$6.02M 0.19% 199
2019
Q1
$31.8M Buy
402,650
+154,175
+62% +$11.3M 0.23% 165
2018
Q4
$16.6M Buy
248,475
+27,825
+13% +$1.93M 0.14% 237
2018
Q3
$17.6M Buy
220,650
+19,750
+10% +$1.47M 0.13% 252
2018
Q2
$13.5M Buy
200,900
+7,850
+4% +$570K 0.11% 283
2018
Q1
$14.8M Buy
+193,050
New +$14.3M 0.12% 243

Other funds holding XYL

Carillon Tower Advisers's XYL Position: Q4 2020 in Review

Carillon Tower Advisers reduced its Xylem (XYL) stake by 11% in Q4 2020, selling an estimated $2.69M and leaving 230,821 shares worth $23.5M. The position accounts for 0.14% of the portfolio, ranked #212.

Carillon Tower Advisers first reported a position in XYL in Q1 2018 and has held it in 12 quarters since. The position peaked at $31.8M in Q1 2019. 734 funds tracked by Wall St. Rank hold XYL as of Q4 2020.

  • Carillon Tower Advisers held 230,821 shares of Xylem worth $23.5M as of Q4 2020.
  • Carillon Tower Advisers sold 28,638 Xylem shares in Q4 2020, an estimated $2.69M.
  • Xylem made up 0.14% of Carillon Tower Advisers's portfolio in Q4 2020, its #212 holding.
  • Carillon Tower Advisers first reported a position in Xylem in Q1 2018 and has held it in 12 quarters since.
  • Carillon Tower Advisers's Xylem position peaked at $31.8M in Q1 2019.
  • 734 funds tracked by Wall St. Rank held Xylem as of Q4 2020.

Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.